LOY tumor cells displayed more dysfunctional and exhausted CD8+ T cells (i.e., higher levels of TOX expression), suggesting that LOY in cancer cells alters T cell function in the surrounding tumor microenvironment. This evidence concerns the gene CD8A and cancer.